Genes such as RLIM, FBL17, FGF7, DDX5, NAV3, and NFASC were found at the intersection of multiple pathways, suggesting they may function as critical effectors of miR-155 and miR-3173 activity in cancer. This evidence concerns the gene FBXL17 and cancer.